Cibler les médicaments à risque pour optimiser la validation pharmaceutique des prescriptions

2011 Michel, 2010, Les évènements indésirables graves associés aux soins observés dans les établissements de santé, Doss Solidar Santé, 17 Dell-Ova, 2014, Médicaments à risque, comment établir une liste ? Bouchet, 2014, Analyse d’ordonnances : recherche d’une méthode pour cibler les patients à risque et les médicaments à risque Coquet, 2012 HAS, 2012 Connolly, 2013, The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study, Circulation, 128, 237, 10.1161/CIRCULATIONAHA.112.001139 Breithardt, 2014, Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial, EurHeart J, 35, 3377, 10.1093/eurheartj/ehu305 ANSM, 2014 Caisse nationale de l’Assurance maladie, 2014 Leape, 1991, The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II, N Engl J Med, 324, 377, 10.1056/NEJM199102073240605 Hoonhout LH1, 2010, Nature, occurrence and consequences of medication-related adverse events during hospitalization: a retrospective chart review in the Netherlands, Drug Saf, 33, 853, 10.2165/11536800-000000000-00000 Dequito, 2011, Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands, Drug Saf, 34, 1089, 10.2165/11592030-000000000-00000 Bates, 1999, Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group, Arch Intern Med, 159, 2553, 10.1001/archinte.159.21.2553 Allenet, 2006, Validation of an instrument for the documentation of clinical pharmacists’ interventions, Pharm World Sci, 28, 181, 10.1007/s11096-006-9027-5 Juste, 2012, Recommandation de bonne pratique en pharmacie clinique. Analyse d’ordonnance et niveaux d’analyse pharmaceutique, Pharm Hosp Clin, 47, 293 Faure, 2010, Anticancéreux cytotoxiques, Actual Pharm, 49, 51 Ranchon, 2009, Sécurisation de l’emploi des chimiothérapies anticancéreuses administrables par voie orale, Pharm Hosp Clin, 44, 36 Sécurité du médicament à l’hôpital – ANSM : Agence nationale de sécurité du médicament et des produits de santé. http://ansm.sante.fr/Dossiers/Securite-du-medicament-a-l-hopital/Securite-du-medicament-a-l-hopital/(offset)/0 [Consulté le 6 juin 2016]. 2014 Houin, 2007, Suivi thérapeutique pharmacologique des digitaliques Lang, 2009, STOPP-START: adaptation of a French language screening tool for detecting inappropriate prescriptions in older people, Can J Public Health, 100, 426, 10.1007/BF03404338 Bedouch, 2008, Assessment of clinical pharmacists interventions in French hospitals: results of a multicenter study, Ann Pharmacother, 42, 1095, 10.1345/aph.1L045 Bedouch, 2012, Computerized physician order entry system combined with on-ward pharmacists: analysis of pharmacists’ interventions, J Eval Clin Pract, 18, 911, 10.1111/j.1365-2753.2011.01704.x